{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:20Z","timestamp":1786119140280,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1097\/mph.0b013e31818e532c","type":"journal-article","created":{"date-parts":[[2008,12,31]],"date-time":"2008-12-31T03:12:34Z","timestamp":1230693154000},"page":"22-26","source":"Crossref","is-referenced-by-count":8,"title":["Minimal Residual Disease in Peripheral Blood Stem Cell Harvests From High-risk Neuroblastoma Patients"],"prefix":"10.1097","volume":"31","author":[{"given":"Smadar","family":"Avigad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Feinberg-Gorenshtein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drorit","family":"Luria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Jeison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Grunshpan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yacov","family":"Sverdlov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifra","family":"Ash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Yaniv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210227","first-page":"931","article-title":"Principles and Practice of Pediatric Oncology, 5th ed","author":"Brodeur","year":"2006"},{"key":"R2-6-20210227","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrc1014","article-title":"Neuroblastoma: biological insights into a clinical enigma","volume":"3","author":"Brodeur","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"R3-6-20210227","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1056\/NEJM199910143411601","article-title":"Treatment of high-risk neuroblastoma with intensive chemotherapy radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group","volume":"341","author":"Matthay","year":"1999","journal-title":"N Engl J Med"},{"key":"R4-6-20210227","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1182\/blood.V84.2.380.380","article-title":"Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells","volume":"84","author":"Rill","year":"1994","journal-title":"Blood"},{"key":"R5-6-20210227","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00043426-200101000-00004","article-title":"Disease outcome may be predicted by molecular detection of minimal residual disease in bone marrow in advanced neuroblastoma: a pilot study","volume":"23","author":"Fukuda","year":"2001","journal-title":"J Pediatr Hematol Oncol"},{"key":"R6-6-20210227","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/1096-911X(20010101)36:1<213::AID-MPO1052>3.0.CO;2-9","article-title":"Minimal residual disease at the time of peripheral blood stem cell harvest in patients with advanced neuroblastoma","volume":"36","author":"Burchill","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"R7-6-20210227","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/1096-911X(20010101)36:1<203::AID-MPO1049>3.0.CO;2-T","article-title":"Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma","volume":"36","author":"Horibe","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"R8-6-20210227","first-page":"812","article-title":"Real-time analysis of tyrosine hydroxylase gene expression: a sensitive and semiquantitative marker for minimal residual disease detection of neuroblastoma","volume":"9","author":"Lambooy","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R9-6-20210227","first-page":"1021","article-title":"Prognostic impact of the detection of microcirculating tumor cells by a real-time RT-PCR assay of tyrosine hydroxylase in patients with advanced neuroblastoma","volume":"14","author":"Parareda","year":"2005","journal-title":"Oncol Rep"},{"key":"R10-6-20210227","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.1158\/1078-0432.CCR-06-0740","article-title":"Peripheral blood stem cell tumor cell contamination and survival of neuroblastoma patients","volume":"12","author":"Corrias","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R11-6-20210227","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1200\/JCO.1991.9.6.1050","article-title":"Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma.","volume":"9","author":"Cheung","year":"1991","journal-title":"J Clin Oncol"},{"key":"R12-6-20210227","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.bmt.1705929","article-title":"Stem cell transplantation for neuroblastoma","volume":"41","author":"Fish","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"R13-6-20210227","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1442-200x.2004.01921.x","article-title":"Comparison of two methods for evaluating bone marrow metastasis of neuroblastoma: reverse transcription-polymerase chain reaction for tyrosine hydroxylase and magnetic resonance imaging","volume":"46","author":"Takemoto","year":"2004","journal-title":"Pediatr Int"},{"key":"R14-6-20210227","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/cncr.20059","article-title":"The predictive potential of molecular detection in the nonmetastatic Ewing family of tumors","volume":"100","author":"Avigad","year":"2004","journal-title":"Cancer"},{"key":"R15-6-20210227","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/(SICI)1097-0142(19960915)78:6<1320::AID-CNCR22>3.0.CO;2-1","article-title":"Minimal disease detection in patients with alveolar rhabdomyosarcoma using a reverse transcriptase-polymerase chain reaction method","volume":"78","author":"Kelly","year":"1996","journal-title":"Cancer"},{"key":"R16-6-20210227","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1365-2141.2000.02244.x","article-title":"A quantitative study of peripheral blood stem cell contamination in diffuse large-cell non-Hodgkin's lymphoma: one-half of patients significantly mobilize malignant cells","volume":"110","author":"Jacquy","year":"2000","journal-title":"Br J Haematol"},{"key":"R17-6-20210227","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/sj.bmt.1703929","article-title":"Prognostic significance of the detection of tumour cells in peripheral blood stem cell collections in stage II and III breast cancer patients treated with high-dose therapy","volume":"31","author":"Patriarca","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"R18-6-20210227","first-page":"47","article-title":"Myeloma cell contamination of peripheral blood stem cell grafts in patients with multiple myeloma treated by high-dose therapy","volume":"14","author":"Mariette","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"R19-6-20210227","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1200\/JCO.1998.16.11.3509","article-title":"Occult tumor contamination of hematopoietic stem-cell products does not affect clinical outcome of autologous transplantation in patients with metastatic breast cancer","volume":"16","author":"Cooper","year":"1998","journal-title":"J Clin Oncol"},{"key":"R20-6-20210227","first-page":"4641","article-title":"Detection of germ-cell tumor cells in peripheral blood progenitor cell harvests: impact on clinical outcome","volume":"6","author":"Hildebrandt","year":"2000","journal-title":"Clin Cancer Res"},{"key":"R21-6-20210227","doi-asserted-by":"crossref","first-page":"7978","DOI":"10.1158\/1078-0432.CCR-04-0815","article-title":"Detection of neuroblastoma cells in bone marrow and peripheral blood by different techniques: accuracy and relationship with clinical features of patients","volume":"10","author":"Corrias","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R22-6-20210227","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/pbc.20022","article-title":"Tumor cells are present in stem cell harvests of Ewing's sarcoma patients and their persistence following transplantation is associated with relapse","volume":"42","author":"Yaniv","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"R23-6-20210227","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ejca.2006.08.007","article-title":"Standardisation of operating procedures for the detection of minimal disease by QRT-PCR in children with neuroblastoma: quality assurance on behalf of SIOPEN-R-NET","volume":"43","author":"Viprey","year":"2007","journal-title":"Eur J Cancer"},{"key":"R24-6-20210227","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/1096-911X(20010101)36:1<210::AID-MPO1051>3.0.CO;2-F","article-title":"Detection of microscopic disease: comparing histology, immunocytology, and RT-PCR of tyrosine hydroxylase, GAGE, and MAGE","volume":"36","author":"Cheung","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"R25-6-20210227","first-page":"821","article-title":"Molecular detection of GAGE expression in peripheral blood and bone marrow: utility as a tumor marker for neuroblastoma","volume":"3","author":"Cheung","year":"1997","journal-title":"Clin Cancer Res"},{"key":"R26-6-20210227","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2353\/jmoldx.2007.060130","article-title":"Cyclin D1, a novel molecular marker of minimal residual disease, in metastatic neuroblastoma","volume":"9","author":"Cheung","year":"2007","journal-title":"J Mol Diagn"},{"key":"R27-6-20210227","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1053\/jpsu.2000.16403","article-title":"Clinical implications of minimal disease in the bone marrow and peripheral blood in neuroblastoma","volume":"35","author":"Shono","year":"2000","journal-title":"J Pediatr Surg"},{"key":"R28-6-20210227","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ijc.21789","article-title":"Sialyltransferase STX (ST8SiaII): a novel molecular marker of metastatic neuroblastoma","volume":"119","author":"Cheung","year":"2006","journal-title":"Int J Cancer"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0b013e31818e532c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:31:28Z","timestamp":1786037488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00043426-200901000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e31818e532c","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}